Jonathan Neilly | cannabisMD

Jonathan Neilly

September 29, 2018
Cannabis is said to make schizophrenia symptoms worse.

Cannabis Worsens Cognitive Function in Schizophrenia

Cannabis remains the most commonly used illegal drugs in individuals having schizophrenia and about 43% of patients using the natural […]
September 28, 2018
Endothelial Dysfunction

CB1 Receptor and Endothelial on Oxygen Species

The important place of cell death and/or impaired endothelial activity in vascular dysfunction development cannot be overemphasized. It is associated […]
September 27, 2018
A Brief Review on Cannabinoids and Migraines

Cannabinoids for Migraine – A Brief Review

The ECS and Migraine Pain This is a brief review of the potential for cannabinoids to be used to treat […]
September 24, 2018
Cannabinoids to Treat Corneal Pain

Using Cannabinoids to Treat Corneal Pain

Damage to the cornea can result in the pain signals from the cornea becoming dysfunctional, increasing sensitivity and producing random […]
September 24, 2018
Usign the ECS to combat pain and inflammation

Targeting the ECS for Pain and Inflammation Relief

There have been few major developments in the area of analgesia for decades. The most recent was opioids in the […]
September 23, 2018
Cannabis as a reliable treatment for Epilepsy

Features That Make Cannabis Reliable for Treating Epilepsy

CBD and THC as Anticonvulsants Cannabis has been used for years for the treatment of several diseases. CBD is the […]
September 21, 2018
A possible therapy for alcohol addiction, cannabiniods

Targeting Alcohol Addiction With Cannabinoids

The abuse of alcohol and other drugs is a societal problem in almost every country on earth. In the western […]
September 20, 2018
Cannabis Sativa, the benefits of cannabiniods

The Potential Benefits of Cannabinoids From Cannabis Sativa

The benefits of the marijuana plant have been written about since at least 2,600 BC. Other evidence suggests it has […]
September 20, 2018
Several Ways Cannabiniods can block pain

Cannabinoids Block Pain in Several Ways

This paper assess how two non-psychoactive cannabinoids, cannabidiol (CBD) and cannabichromene (CBC), alter the perception of pain in anaesthetized rats. […]